New Market Research Report: AtriCure, Inc. (ATRC) - Product Pipeline Analysis, 2014 Update

Boston, MA -- (SBWIRE) -- 06/05/2014 -- AtriCure, Inc. (AtriCure) is a medical device company. It carries out the development, manufacture and sales of innovative cardiac surgical ablation devices. The company's ablation devices are designed to create precise lesions or scars in cardiac and soft tissues. The major products of the company include AtriCure Synergy Ablation System, a bipolar ablation clamp system and related radiofrequency ablation devices; Estech's radio frequency ablation devices; AtriClip left atrial appendage (LAA) occlusion system; and a cryoablation product line that features reusable and disposable cryoablation devices. The company markets and sells its products in selected markets outside of the US through independent distributors and through its European subsidiary in EMEA markets. AtriCure is headquartered in Ohio, the US.